Bengaluru: Stock three main drugs used to treat Covid-19 in the country warehouse enough to last a month and only a small portion of the recommended amount, data shows.
The state government has now issued a purchase order for the procurement of Tocilizumab antivirus drugs, Dexametasone steroids and antifungal posaconazole.
To overcome the third wave, the center has instructed the country to ensure stock buffers from eight important drugs needed to treat Covid-19, and, based on consumption during the second wave, have also determined the required quantity.
Eight drugs are heparin anticoagulants, steroid methylprednisolone, dexamethasone (injection), antiviral remedies, tovilizumab, antifungal amphotericin b (injection), posaconazole (injection), and intravenous immunoglobulin (injection).
While Karnataka has a stock of other drugs in the amount of determined, it lacks tocilizumab buffer supplies, dexamethasone and posaconazole.
At present, the number of Todilizumab in stock is only 10.
8% of what has been recommended the center, DDExamethasone 3%, and posaconazole 12.6%.
When talking about preparation for the third wave on Thursday, Minister of Health K Sudhakar said there was a problem regarding the supply of dexamethasone and posaconazol.
“Stock Dexamethasone is low compared to the center directives on buffer shares,” he said.
“We bought more than 10 lakh more doses.
Postaconazole injection is not available on the market, even though we strive to buy more.” About Todilizumab, a minister says experts in the state are not needed in large quantities and these countries only have 699 dosage.
However, KS Latha.
However, KS Latha.
Kumari, IAS, Managing Director, Karnataka State Medical Supplies Corporation Ltd (KSMSCL), insisted on no shortage of drugs.
He said the country had enough stock of three drugs for another month.
“The sequence of procurement has been issued and we have been issued and we.
Expect the immediate supply,” said Latha, added that the previous two tenders had no response but there was enough bidder now.
The state has issued an order to buy 13.
2 lakh dexamethasone doses, 4,285 posaconazol, and 4,901 from Tocedazumab.
Data with KSMSCL shows a sufficient amount of five other drugs.
The country has 10.
3 doses of lakh or 80% of heparin shares suggested by the center, 2.
3 doses of methylprednisolone (200% of the stock buffer needed) A nd 4.
3 lakh dose remdesivir (73% of the mandate center).
Can be recalled that during the second wave, the state has faced the acute deficiency of amphotericin b injection which is needed to treat post-covid complications of mucatorcosis.
Towards the third wave, the state has 33,364 drug doses and has also issued purchase orders for 70,911 additional doses.
Karnataka stocks from the three main drugs to treat Covid-19 will last only a month
